1. Home
  2. |Insights
  3. |Third Circuit Holds that MA organizations have a direct right of recovery under the Medicare Secondary Payer (MSP) Act

Third Circuit Holds that MA organizations have a direct right of recovery under the Medicare Secondary Payer (MSP) Act

Client Alert | 2 min read | 06.28.12

The Third Circuit has held that Medicare Advantage organizations (MAOs) have a direct right of recovery against primary payers under the Medicare Secondary Payer (MSP) Act. The Third Circuit decision arises out of a lawsuit brought by Humana, Inc., as an MAO, to recover for medical expenses paid by Humana on behalf of Medicare beneficiaries related to the use of Avandia, a drug marketed by GlaxoSmithKline (GSK). The decision is In re: Avandia Marketing, Sales Practices and Products Liability Litigation, GlaxoSmithKline, LLC, No. 11-2664 (3rd Cir. June 28, 2012).

The court held specifically that the MSP provision in 42 U.S.C. § 1395y(b)(3)(A), provides MAOs with a private cause of action against primary payers. The court's decision is based on the plain text of Section 1395y(b)(3)(A), which establishes "a private cause of action for damages (which shall be in an amount double the amount otherwise provided) in the case of a primary plan which fails to provide for primary payment (or appropriate reimbursement) in accordance with [the requirements of the MSP Act]."

The court held that the plain text of this provision "sweeps broadly enough to include MAOs," such that MAOs are proper plaintiffs to recover under the terms of the statutory provisions. The court also noted that even if it had determined the statute to be ambiguous on this point, it would have deferred to CMS regulations stating that MAOs have the same right to recover as the Medicare Trust Fund does under the MSP Act.

As the court noted, prior cases in which MAOs had unsuccessfully sought a federal cause of action were not premised on 42 U.S.C. § 1395y(b)(3)(A), but on specific Medicare Advantage provisions of the Medicare Act. The court held that these prior cases were largely irrelevant to deciding the issue before it. The decision gives MAOs an important new tool for attempting to recover from primary payers for Medicare covered expenses, in addition to being able to continue using subrogation and other related legal remedies.

Crowell & Moring attorneys Art Lerner, Barbara Ryland and Amy Tridgell submitted an amicus brief on behalf of America's Health Insurance Plans in support of Humana's position.

 

Contacts

Insights

Client Alert | 4 min read | 09.10.26

European Commission Publishes Landmark Guidelines on Exclusionary Abuses by Dominant Companies

On 3 September 2026, the European Commission adopted new Guidelines on the application of Article 102 TFEU to abusive exclusionary conduct by dominant undertakings. The Guidelines follow a public consultation on a draft published in August 2024 and reflect substantial stakeholder feedback. They replace the Commission's 2008 Guidance on enforcement priorities (which ceases to apply 30 days after publication of the new guidelines in the Official Journal) and represent the most significant reset of the Commission's Article 102 enforcement framework in nearly two decades. The Commission's stated aim is to set out principles and operational guidance, enhance legal certainty, and help companies self-assess their exclusionary-abuse risk....